Life Insurance Corporation Of India-Backed Pharma Company Hits Fresh 52-Week High; Share Price Gains Over 3% On Monday

Indian equity markets traded lower on Monday, with the benchmark Nifty 50 index declining 0.92 per cent to 23,952.80. Despite weakness in the broader market, stock-specific buying interest remained visible in select pharmaceutical counters. In this segment, Laurus Labs remained in focus after the stock witnessed buying momentum during the session. Laurus Labs share price gained 3.53 per cent to close at Rs 1,271.70 on Monday.

Laurus Labs Share Price Performance

Laurus Labs shares have delivered strong returns across multiple time periods. The stock has gained 16.91 per cent over the past one month, while it has surged 29.01 per cent during the last six months. On a one-year basis, Laurus Labs share price has rallied 114.29 per cent.

The stock touched its fresh 52-week high of Rs 1,274.50 on May 11, 2026, while the 52-week low stands at Rs 572.25 recorded on May 09, 2025. The company currently has a market capitalisation of Rs 68,575 crore.

Laurus Labs Shareholding Pattern

As per the latest shareholding pattern for March 2026, promoters held a 27.49 per cent stake in Laurus Labs, unchanged compared to December 2025. Foreign Institutional Investors reduced their holding marginally to 25.82 per cent from 26.52 per cent in the previous quarter.

Domestic Institutional Investors increased their stake to 13.96 per cent in March 2026 compared to 12.42 per cent held in December 2025, while public shareholding declined to 32.73 per cent from 33.57 per cent during the same period.

About Laurus Labs

Laurus Labs is an Indian pharmaceutical and biotechnology company engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), finished dosage formulations, biotechnology products and specialty ingredients. The company supplies products across therapeutic areas including anti-retroviral, oncology, cardiovascular, gastroenterology and diabetes segments.

The company operates manufacturing and research facilities across India and serves customers in multiple international markets including the United States, Europe and emerging economies. Laurus Labs also focuses on contract development and manufacturing services (CDMO) along with biotechnology and synthesis businesses.

Share your views on Laurus Labs’ recent share price performance in the comments below.
Disclaimer: This article is for informational purposes only and not investment advice